AssetMark’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
SL
AssetMark's IRON Position: Q3 2026 in Review
AssetMark increased its Disc Medicine (IRON) stake by 33% in Q3 2026, buying an estimated $302 and bringing the position to 16 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #3221.
AssetMark first reported a position in IRON in Q1 2025 and has held it in 7 quarters since. 150 funds tracked by Wall St. Rank hold IRON as of Q3 2026.
- AssetMark held 16 shares of Disc Medicine worth $1.05K as of Q3 2026.
- AssetMark bought 4 Disc Medicine shares in Q3 2026, an estimated $302.
- Disc Medicine made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3221 holding.
- AssetMark first reported a position in Disc Medicine in Q1 2025 and has held it in 7 quarters since.
- 150 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.